These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 10516690

  • 1. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
    James R, May C, Diers M, Wagner J, McIvor R.
    Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
    [Abstract] [Full Text] [Related]

  • 2. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI, May C, Vagt MD, Studebaker R, McIvor RS.
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR, James RI, May C, Diers MD, Swanson D, Gunther R, McIvor RS.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
    Belur LR, Boelk-Galvan D, Diers MD, McIvor RS, Zimmerman CL.
    Cancer Res; 2001 Feb 15; 61(4):1522-6. PubMed ID: 11245460
    [Abstract] [Full Text] [Related]

  • 5. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
    McIvor RS.
    Bone Marrow Transplant; 1996 Dec 15; 18 Suppl 3():S50-4. PubMed ID: 8971409
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
    May C, James RI, Gunther R, McIvor RS.
    J Pharmacol Exp Ther; 1996 Sep 15; 278(3):1444-51. PubMed ID: 8819532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P, Lu Y, Pang K, Wang SB, Chen JQ, Xu HM, Wang JK, Zhao SC.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):998-1001. PubMed ID: 16194358
    [Abstract] [Full Text] [Related]

  • 9. Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.
    Sweeney CL, Frandsen JL, Verfaillie CM, McIvor RS.
    Cancer Res; 2003 Mar 15; 63(6):1304-10. PubMed ID: 12649191
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB, McIvor RS.
    J Pharmacol Exp Ther; 1993 Nov 15; 267(2):989-96. PubMed ID: 8246174
    [Abstract] [Full Text] [Related]

  • 12. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
    Braun SE, McIvor RS, Davidson AS, Hanna M, Traycoff CM, Berebetsky DA, Gonin R, Broxmeyer HE, Cornetta K.
    Cancer Gene Ther; 1997 Nov 15; 4(1):26-32. PubMed ID: 9012448
    [Abstract] [Full Text] [Related]

  • 13. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N, Nakahara S, Zhao SC, Adhikari D, Ural AU, Iwamoto M, Banerjee D, Bertino JR.
    Cancer Gene Ther; 2000 Jun 15; 7(6):910-9. PubMed ID: 10880023
    [Abstract] [Full Text] [Related]

  • 14. Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
    Mineishi S, Nakahara S, Takebe N, Zhao SC, Banerjee D, Bertino JR.
    Cancer Gene Ther; 1998 Jun 15; 5(3):144-9. PubMed ID: 9622097
    [Abstract] [Full Text] [Related]

  • 15. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J, Gu LJ, Ying DM, Shen M, Wu HJ.
    Ai Zheng; 2002 Dec 15; 21(12):1335-40. PubMed ID: 12520743
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
    Mineishi S, Nakahara S, Takebe N, Banerjee D, Zhao SC, Bertino JR.
    Gene Ther; 1997 Jun 15; 4(6):570-6. PubMed ID: 9231073
    [Abstract] [Full Text] [Related]

  • 18. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
    Banerjee D, Zhao SC, Tong Y, Steinherz J, Gritsman K, Bertino JR.
    Cancer Gene Ther; 1994 Sep 15; 1(3):181-4. PubMed ID: 7621249
    [Abstract] [Full Text] [Related]

  • 19. Expression of a methotrexate resistant dihydrofolate reductase gene in transgenic mice.
    Isola LM, Gordon JW.
    Dev Genet; 1989 Sep 15; 10(5):349-55. PubMed ID: 2480860
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
    Gori JL, Podetz-Pedersen K, Swanson D, Karlen AD, Gunther R, Somia NV, McIvor RS.
    J Pharmacol Exp Ther; 2007 Sep 15; 322(3):989-97. PubMed ID: 17586722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.